HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jeffrey Eastham-Anderson Selected Research

Psoriasis (Pustulosis Palmaris et Plantaris)

2/2007Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jeffrey Eastham-Anderson Research Topics

Disease

17Neoplasms (Cancer)
04/2019 - 01/2008
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2020 - 01/2017
2Melanoma (Melanoma, Malignant)
04/2019 - 01/2017
2Disease Progression
01/2019 - 01/2013
2Hypoxia (Hypoxemia)
11/2017 - 08/2012
2Inflammation (Inflammations)
02/2016 - 02/2007
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2013 - 01/2012
2Neoplasm Metastasis (Metastasis)
08/2012 - 04/2010
1Mesothelioma
04/2019
1Colorectal Neoplasms (Colorectal Cancer)
01/2018
1Adenocarcinoma of Lung
11/2017
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
11/2017
1Lung Injury
11/2017
1Proteinuria
01/2017
1Lupus Nephritis
01/2017
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2017
1Choroidal Neovascularization
02/2016
1Macular Degeneration (Age-Related Maculopathy)
02/2016
1Colonic Neoplasms (Colon Cancer)
11/2015
1Ulcerative Colitis
07/2014
1Pneumonia (Pneumonitis)
12/2013
1Infections
12/2013
1Prostatic Neoplasms (Prostate Cancer)
07/2013
1Crush Injuries
03/2013
1Primitive Neuroectodermal Tumors (PNET)
08/2012
1Residual Neoplasm
01/2012
1Multiple Sclerosis
09/2010
1Demyelinating Diseases (Demyelinating Disease)
01/2010
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2010
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2010
1Breast Neoplasms (Breast Cancer)
06/2009
1Pituitary Neoplasms (Pituitary Adenoma)
01/2008
1Multiple Endocrine Neoplasia Type 1
01/2008
1Psoriasis (Pustulosis Palmaris et Plantaris)
02/2007
1Autoimmune Diseases (Autoimmune Disease)
02/2007

Drug/Important Bio-Agent (IBA)

6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2017 - 01/2008
4Proteins (Proteins, Gene)FDA Link
01/2017 - 01/2010
2Deubiquitinating EnzymesIBA
04/2019 - 01/2010
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2018 - 01/2017
2AntibodiesIBA
09/2013 - 04/2010
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
03/2013 - 09/2011
2LigandsIBA
08/2012 - 06/2009
2Trastuzumab (Herceptin)FDA Link
09/2011 - 06/2009
2CytokinesIBA
01/2010 - 02/2007
1IgG Receptors (Fc gamma RI)IBA
01/2020
1Antigen Receptors (Antigen Receptor)IBA
01/2020
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2020
1Histones (Histone)IBA
04/2019
1Biomarkers (Surrogate Marker)IBA
01/2018
1Bispecific AntibodiesIBA
01/2018
1ParaffinIBA
01/2018
1Formaldehyde (Formol)FDA Link
01/2018
1ProdrugsIBA
11/2017
1Tirapazamine (SR 4233)IBA
11/2017
1Transcription Factors (Transcription Factor)IBA
11/2017
1Bleomycin (Blenoxane)FDA LinkGeneric
11/2017
1Mitogen-Activated Protein KinasesIBA
01/2017
1OX40 LigandIBA
01/2017
1Phosphotransferases (Kinase)IBA
01/2017
1Interleukin-33IBA
02/2016
1Retinal Pigments (Pigments, Visual)IBA
02/2016
1Immunoconjugates (Immunoconjugate)IBA
11/2015
1etrolizumabIBA
07/2014
1AllergensIBA
12/2013
1Peptide Hydrolases (Proteases)FDA Link
12/2013
1Oxygen (Dioxygen)IBA
11/2013
11- (4- ((2- (2- aminopyrimidin- 5- yl)- 7- methyl- 4- morpholinothieno(3,2- d)pyrimidin- 6- yl)methyl)piperazin- 1- yl)- 2- hydroxypropan- 1- oneIBA
11/2013
1TOR Serine-Threonine KinasesIBA
07/2013
1MTOR InhibitorsIBA
07/2013
1TensinsIBA
03/2013
1Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2013
1Sunitinib (Sutent)FDA Link
08/2012
1Phosphoprotein Phosphatases (Phosphatases, Protein)IBA
09/2011
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
04/2010
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
04/2010
1Placenta Growth FactorIBA
04/2010
1Blocking AntibodiesIBA
04/2010
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2010
1Oncogene Proteins (Oncogene Protein)IBA
01/2010
1Laminin (Merosin)IBA
06/2009
12- (1H- indazol- 4- yl)- 6- (4- methanesulfonylpiperazin- 1- ylmethyl)- 4- morpholin- 4- ylthieno(3,2- d)pyrimidineIBA
06/2009
1Docetaxel (Taxotere)FDA Link
06/2009
1Lapatinib (GW572016)FDA Link
06/2009
1pertuzumabIBA
06/2009
1Phenobarbital (Luminal)FDA Link
06/2009
1Neuregulin-1 (Neuregulin 1)IBA
06/2009
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
06/2009
1Monoclonal AntibodiesIBA
01/2008
1ProlactinIBA
01/2008
1Interleukin-17 (Interleukin 17)IBA
02/2007
1Interleukin-22 (IL-22)IBA
02/2007
1InterleukinsIBA
02/2007

Therapy/Procedure

11Therapeutics
01/2019 - 06/2009
2Immunotherapy
01/2019 - 01/2018
1Drug Therapy (Chemotherapy)
01/2012